Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
pantovigar + minoxidil
- Development stage
- Unknown
- Lead developer
- Merz
- Modality
- Small Molecules
- Administration
- Oral, Topical
01
Overview
**Pantovigar + minoxidil** is a combination therapy involving oral administration of Pantovigar, a multi-ingredient dietary supplement formulated to treat diffuse hair loss and damaged hair (primarily in women), together with topical minoxidil, a small-molecule vasodilator widely used for promoting scalp hair growth. The typical regimen consists of Pantovigar capsules taken orally three times daily and 2% minoxidil solution applied topically to the scalp twice daily. This combination is primarily indicated for the treatment of **female pattern hair loss** (androgenetic alopecia of Ludwig Type 1 and 2) and has been evaluated for efficacy and tolerability in randomized clinical trials for this indication. The hypothesized mechanism involves nutritional and metabolic support to hair follicles from Pantovigar alongside stimulation of hair follicle activity through enhanced scalp blood flow delivered by minoxidil[1][2].
- Brand names
- Pantovigar + Minoxidil
- Other names
- Pantovigar plus MinoxidilPantovigar and Minoxidil combination
02
Targets
KATP channel (ATP-sensitive potassium channel)
Beyond the preview
Go deeper on pantovigar + minoxidil.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on pantovigar + minoxidil.